We are monitoring the impact of COVID-19 on MEA Hyaluronic Acid Products Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7726
Share on
Share on

Middle East and Africa Hyaluronic Acid Products Market Research Report – Segmented By Product type, Application and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7726
Pages: 145

MEA Hyaluronic Acid Products Market Size (2021 to 2026)

The size of the Hyaluronic Acid Products market in the Middle East and Africa was around USD 0.81 Billion in 2021. It is expected to grow at a CAGR of 6.5% to reach USD 1.11 billion by 2026.

The growth of the MEA hyaluronic acid products market is increasing for the aging population due to the increasing prevalence of osteoarthritis, ophthalmic plastic surgeries, and derma-fillers. Hence the growing rate of the senior population, increased awareness of hyaluronic acid products in the MEA region are driving the market. According to the WHO, the world's population over 60 will double from 13% to 23% from 2015-2050. Between 2020 and 2050, Africa's elderly population is expected to triple from 74.8 million to 237.7 million. Its growth over the next three decades is estimated to exceed that of any other region in the world. According to a recent study, the total population of senior Saudis was estimated at 859,500, representing 5.4% of the total population of Saudi citizens. Saudi Arabia is one of the largest economies in the Middle East region, with growing demand for generics and the growing expansion of international players in the country have enabled substantial growth in the pharmaceutical industry to produce hyaluronic acid products.

The demand for hyaluronic acid products will increase as bone-related issues are likely to be at their highest in the coming years, coupled with the need for minimally invasive procedures, which is expected to drive market growth. Hyaluronic acid is available in the form of dietary supplements, pills, injections in the market for people who have low levels of hyaluronic acid in their bodies.  Glycosaminoglycan are rich in hyaluronic acid helps to alleviate inflammatory conditions; hence they use extensively in the medical sector. Hyaluronic acid is used as injectable filler to smooth age-related wrinkles, hide recessed scars, and increase and define the contours of the face and other body areas. It is also commonly used in skin care products to provide softer, hydrated, and radiant skin due to its moisture-retaining characteristics. Moreover, the constant evolution in healthcare technology and an increase in R&D activities lead to the development of the MEA hyaluronic acid products market.

However, several factors are responsible for restraining the MEA hyaluronic acid products market, such as high price, poor healthcare awareness due to inadequate medical facilities, side effects of hyaluronic acid use like itchiness, soreness, redness, and discoloration, etc.

This research report on the MEA hyaluronic acid products market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Single Cycle Injection Products
  • Three Cycle Injection Projects
  • Five Cycle Injection Products

By Application:

  • Osteoarthritis
  • Ophthalmic
  • Dermal Fillers
  • Vesicoureteral Reflux

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Over the forecast period, the Middle East region is expected to dominate the MEA market. Countries in the Middle East and Africa are emerging as attractive outsourcing destinations for the pharmaceutical and biopharmaceutical industries to increase the production rate. The aging population of the UAE will likely increase the hyaluronic acid products in the UAE. In 2018, the Dubai Health Authority reported that the local elderly population would go from 7% to 30% by 2050. Additionally, the booming domestic pharmaceutical market, growing research and development sector, and high rate of cosmetic procedures will drive the sale numbers in the region. Osteoarthritis is one of the leading causes of disability in the UAE, with around 52% of the senior population is suffering from chronic conditions. About 26% of people over 60 suffer from severe pain and disability caused by osteoarthritis, providing market growth opportunities for hyaluronic acid products in the years to come.

In 2019, Saudi Arabia had a high CAGR of 7% for the studied market. This market growth can be attributed to the increase in the aging population, a well-developed pharmaceutical industry, and the high production of drugs. These factors are expected to positively impact the Saudi Arabia hyaluronic acid products market during the forecast period.


Allergan, Sanofi, Ferring B.V., Zimmer Biomet, Fidia Farmceutici, Salix Pharmaceutical, Anika Therapeutics, Seikagaku Corporation, Hoffmann-LA Roche Ltd, Alcon, Inc., Smith & Nephew plc and F.Merz Asthetics, Inc. are expected to play a leading role in the MEA hyaluronic acid products market during the forecast period.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Introduction           

                                5.1.2 Single Cycle Injection Products       

                                5.1.3 Three Cycle Injectin Products         

                                5.1.4 Five cycle injection Products           

                                5.1.5  Y-o-Y Growth Analysis, By Product Type   

                                5.1.6  Market Attractiveness Analysis, By Product Type

                                5.1.7  Market Share Analysis, By Product Type   

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Osteoarthritis        

                                5.2.3 Ophthalmic             

                                5.2.4 Dermal Filler           

                                5.2.5 Vesicoureteral Reflux         

                                5.2.5 Y-o-Y Growth Analysis, By Application         

                                5.2.6 Market Attractiveness Analysis, By Application       

                                5.2.7 Market Share Analysis, By Application        

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Home        

                                5.3.4 Clinics        

                                5.3.5  Y-o-Y Growth Analysis, By End User            

                                5.3.6  Market Attractiveness Analysis, By End User          

                                5.3.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Product Type

                                       By Application

                                       By End User

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Product Type

                                       By Application

                                       By End User

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Product Type

                                       By Application

                                       By End User

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Zimmer Biomet                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 StemCells                    

                8.3 Allergan                       

                8.4 Sanofi                           

                8.5 Ferring B.V                  

                8.6 Fidia Farmceutici                      

                8.7 Salix Pharmaceutical                               

                8.8 Anika Therpeutics                    

                8.9 Seikagaku Corporation                          

                8.10 Hoffmann-LA Roche Ltd                     

                8.11 Smith & nephew plc.                            

                8.12 F.Merz Asthetics, inc                            

                8.13 Alcon                          

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Product Type, by  Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market


  1. Middle East and Africa Hyaluronic Acid Products Market, By Product Type, From 2021 to 2026 (USD Million)
  2. Middle East and Africa Single cycle injection products Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East and Africa Three cycle injection products Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East and Africa Five cycle injection produtcs Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East and Africa Hyaluronic Acid Products Market, By Application, From 2021 to 2026 (USD Million)
  6. Middle East and Africa Osteoarthritis Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East and Africa Ophthalmic Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East and Africa Dermal Fillers Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East and Africa Vesicoureteral Reflux Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East Hyaluronic Acid Products Market, By Product Type, From 2021 to 2026 (USD Million)
  11. Middle East Hyaluronic Acid Products Market, By Application, From 2021 to 2026 (USD Million)
  12. Africa Hyaluronic Acid Products Market, By Product Type, From 2021 to 2026 (USD Million)
  13. Africa Hyaluronic Acid Products Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample